Telecoms case highlights risks from foreign pharma 'bullies' say lobbyists
This article was originally published in Scrip
Executive Summary
A Russian conglomerate's plans to invoke a right to protect an Indian investment under the India-Russia bilateral treaty shows the risks to which India could expose its healthcare segment if the controversial "investor-to-state" dispute settlement mechanism forms part of the proposed EU-India free trade agreement, Indian firms and NGOs have warned.